(Total Views: 294)
Posted On: 09/19/2023 8:36:07 AM
Post# of 30067
.jpg)
At some point MANF to the eye is a minimal risk, must have investment. This is great news for the entire field of gene therapy for Opthalmology and great news for patients with Wolfeams, RAO, RP etc
https://www.bbc.com/news/science-environment-36101786.amp
https://www.bbc.com/news/science-environment-36101786.amp

